These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides]. Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905 [TBL] [Abstract][Full Text] [Related]
8. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in maternal serum screening for Down syndrome. Messerlian GM; Canick JA Med Health R I; 2002 Dec; 85(12):362-5. PubMed ID: 12593353 [TBL] [Abstract][Full Text] [Related]
11. Prenatal screening for Down syndrome. Ogle RF; Chitty LS Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057 [TBL] [Abstract][Full Text] [Related]
12. Fetal pyelectasis: does fetal gender modify the risk of major trisomies? Bornstein E; Barnhard Y; Donnenfeld A; Ferber A; Divon MY Obstet Gynecol; 2006 Apr; 107(4):877-9. PubMed ID: 16582126 [TBL] [Abstract][Full Text] [Related]
13. Maternal serum screening of Palestinian women in the West Bank. Husseini A; Akkawi M East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399 [TBL] [Abstract][Full Text] [Related]
14. [Prenatal diagnosis of 95 cases by cytogenetic analysis of early chorionic villi]. Sun NH Zhonghua Fu Chan Ke Za Zhi; 1987 Mar; 22(2):79-81, 125-6. PubMed ID: 2957181 [No Abstract] [Full Text] [Related]
15. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years. Biggio JR; Morris TC; Owen J; Stringer JS Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005 [TBL] [Abstract][Full Text] [Related]
16. The significance of a positive second trimester serum screen for trisomy 18. Oyelese Y; Tobon L; Burton A; Adamczak J; Ashkinadze E; Smulian JC; Canterino J J Matern Fetal Neonatal Med; 2010 Jul; 23(7):633-7. PubMed ID: 20540657 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Sparks AB; Struble CA; Wang ET; Song K; Oliphant A Am J Obstet Gynecol; 2012 Apr; 206(4):319.e1-9. PubMed ID: 22464072 [TBL] [Abstract][Full Text] [Related]
18. Combining first and second trimester markers for Down syndrome screening: think twice. Cocciolone R; Brameld K; O'Leary P; Haan E; Muller P; Shand K Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):492-500. PubMed ID: 19032666 [TBL] [Abstract][Full Text] [Related]
19. Is second-trimester genetic amniocentesis for trisomy 18 ever indicated in the presence of a normal genetic sonogram? Oyelese Y; Vintzileos AM Ultrasound Obstet Gynecol; 2005 Dec; 26(7):691-4. PubMed ID: 16308891 [No Abstract] [Full Text] [Related]
20. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation. Kagan KO; Anderson JM; Anwandter G; Neksasova K; Nicolaides KH Prenat Diagn; 2008 Dec; 28(13):1209-13. PubMed ID: 19039823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]